Research Presentation Sessions: Neuro

RPS 211 - CNS infection and inflammation

Lectures

1
Olfactory bulb MRI in mild to moderate COVID-19

Olfactory bulb MRI in mild to moderate COVID-19

07:00Moritz Castor, Vienna / AT

2
Signal intensity in cranial nerves in COVID-19

Signal intensity in cranial nerves in COVID-19

07:00Sara Gómez Peña, Madrid / ES

3
Quantitative T1 mapping reveals changes after COVID-19 in specific brain regions: a prospective observational case-control study

Quantitative T1 mapping reveals changes after COVID-19 in specific brain regions: a prospective observational case-control study

07:00Christophe Arendt, Frankfurt am Main / DE

4
FDG PET CT in the neurological complications of COVID-19

FDG PET CT in the neurological complications of COVID-19

07:00Nikhil Seniaray, New Delhi / IN

5
Pre-and post-mortem MRI evaluation in COVID-19

Pre-and post-mortem MRI evaluation in COVID-19

07:00Simonetta Gerevini, Cremona / IT

6
Yield of high-resolution vessel wall magnetic resonance imaging in patients with tuberculous meningitis: a prospective study from a tertiary care hospital

Yield of high-resolution vessel wall magnetic resonance imaging in patients with tuberculous meningitis: a prospective study from a tertiary care hospital

07:00Shailly Sonker, Jodhpur / IN

7
Diagnostic Value of Gadolinium-Enhanced SWI Sequences in Multiple Sclerosis

Diagnostic Value of Gadolinium-Enhanced SWI Sequences in Multiple Sclerosis

07:00Cristina Fagotti, L'Aquila / IT

8
Estimation of white matter hyperintensities with synthetic MRI myelin volume fraction in patients with multiple sclerosis and non-MS white matter hyperintensities

Estimation of white matter hyperintensities with synthetic MRI myelin volume fraction in patients with multiple sclerosis and non-MS white matter hyperintensities

07:00Nisha Syed Nasser, Delhi / IN

9
MR-Planimetry in multiple sclerosis: potential biomarker predicting clinical disease severity

MR-Planimetry in multiple sclerosis: potential biomarker predicting clinical disease severity

07:00Stephanie Mangesius, Innsbruck / AT

10
Clinical validity of quantitative AI software-assisted monitoring in multiple sclerosis: comparison with neuroradiological visual assessment and clinical correlates

Clinical validity of quantitative AI software-assisted monitoring in multiple sclerosis: comparison with neuroradiological visual assessment and clinical correlates

07:00Federico Bruno, L'Aquila / IT

11
Assessment of the agreement for detection of optic nerve lesions on 3D double inversion recovery sequence magnetic resonance imaging

Assessment of the agreement for detection of optic nerve lesions on 3D double inversion recovery sequence magnetic resonance imaging

07:00Hawa Kalamou, LILLE / FR

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.